Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Andrew Pecora Insider Profile
4 Followers
Andrew Pecora, Director at Lisata Therapeutics, holds 386.28K shares in Lisata Therapeutics (Ticker: LSTA), holds ― shares in Celularity (Ticker: CELU), holds 184.83K shares in Tetralogic Pharma (Ticker: TLOG).
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-77.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Andrew Pecora holds in companies
Most Profitable Insider Trade
The most profitable trade made by Andrew Pecora
Andrew Pecora's Trading History
Lisata Therapeutics
Jun 23, 2016
Director
Uninformative Buy
―
$1.03M
Celularity
―
President
―
―
Tetralogic Pharma
Jul 14, 2015
Director
Informative Buy
133.81K
$1.85K
Vyant Bio
Nov 20, 2013
―
Informative Sell
713.16K
$463.85
List of latest transactions for each holding click on a transaction to see Andrew Pecora's performance on stock
You May Also Like
Andrew Pecora insider profile FAQ
What is the percentage of profitable transactions made by Andrew Pecora?
The percentage of profitable transactions made by Andrew Pecora is 0%.
What is the average return per transaction made by Andrew Pecora?
The average return per transaction made by Andrew Pecora is -77.80%.
What stocks does Andrew Pecora hold?
Andrew Pecora holds: LSTA, CELU, TLOG, VYNT stocks.
What was Andrew Pecora’s latest transaction?
Andrew Pecora latest transaction was an Uninformative Buy of ―.
What was Andrew Pecora's most profitable transaction?
Andrew Pecora’s most profitable transaction was an Informative Buy of TLOG stock on November 19, 2014. The return on the trade was -64.70%.
What is Andrew Pecora's role in Lisata Therapeutics?
Andrew Pecora's role in Lisata Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.